
Voglibose
CAS No. 83480-29-9
Voglibose( AO-128, AO 128, Glustat, Voglibose, Voglib )
Catalog No. M19157 CAS No. 83480-29-9
Voglibose, an N-substituted derivative of valiolamine, exhibits excellent inhibitory activity against α-glucosidases and action against hyperglycemia and various disorders caused by hyperglycemia.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
25MG | 41 | In Stock |
![]() ![]() |
50MG | 59 | In Stock |
![]() ![]() |
100MG | 88 | In Stock |
![]() ![]() |
200MG | 133 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameVoglibose
-
NoteResearch use only, not for human use.
-
Brief DescriptionVoglibose, an N-substituted derivative of valiolamine, exhibits excellent inhibitory activity against α-glucosidases and action against hyperglycemia and various disorders caused by hyperglycemia.
-
DescriptionVoglibose is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. Voglibose delays the absorption of glucose thereby reducing the risk of macrovascular complications. Voglibose was first launched in 1994, under the trade name BASEN, to improve postprandial hyperglycemia in diabetes mellitus. Postprandial hyperglycemia (PPHG) is primarily due to first phase insulin secretion. Alpha glucosidase inhibitors delay glucose absorption at the intestine level and thereby prevent sudden surge of glucose after a meal. There are three drugs which belong to this class, acarbose, miglitol and voglibose, of which voglibose is the newest. Voglibose has fewer side effects than both acarbose and miglitol. But acarbose has an edge over voglibose in terms of efficacy (FPG, PPHG, HBA1c).
-
In Vitro——
-
In Vivo——
-
SynonymsAO-128, AO 128, Glustat, Voglibose, Voglib
-
PathwayEndocrinology/Hormones
-
TargetRAAS
-
Recptorα-glucosidase
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number83480-29-9
-
Formula Weight267.28
-
Molecular FormulaC10H21NO7
-
Purity>98% (HPLC)
-
SolubilityH2O : ≥ 200 mg/mL; 748.28 mM
-
SMILES[C@]1([C@H]([C@@H]([C@H]([C@H](C1)NC(CO)CO)O)O)O)(O)CO
-
Chemical Name(1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
Terlakiren
Terlakiren (CP-80,794) is an orally active, potent renin inhibitor used in the study of neurological disorders related to hypertension.
-
Plantainoside D
Plantainoside D shows potent antioxidative effects as those of ascorbic acid it shows angiotensin-converting enzyme (ACE) inhibitory inhibitory activity in vitro with the IC(50) value of 2.17 mM it also shows inhibitory activity against PKCalpha with the IC50 value14.8microM.?
-
N-Acetyl-Ser-Asp-Lys...
Acetyl Ser-Asp-Lys-Pro is formed in bone marrow cells by enzymatic processing of thymosin β4. It inhibits the entry of pluripotent hemopoietic stem cells into S-phase of the cell cycle and protects against Ara-C lethality in mice.N-Acetyl-Ser-Asp-Lys-Pro (AcSDKP) is a specific substrate for the N-terminal site of ACE and increases 5-fold during ACE inhibitor therapy.??AcSDKP inhibited the proliferation of isolated cardiac fibroblasts (P<0.05) but significantly stimulated the proliferation of vascular smooth muscle cells.?